These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 38186999)
1. Exosome-mediated macrophage regulation for inflammatory bowel disease repair: a potential target of gut inflammation. Ma F; Zhang S; Akanyibah FA; Zhang W; Chen K; Ocansey DKW; Lyu C; Mao F Am J Transl Res; 2023; 15(12):6970-6987. PubMed ID: 38186999 [TBL] [Abstract][Full Text] [Related]
2. The pentacyclic triterpene Lupeol switches M1 macrophages to M2 and ameliorates experimental inflammatory bowel disease. Zhu Y; Li X; Chen J; Chen T; Shi Z; Lei M; Zhang Y; Bai P; Li Y; Fei X Int Immunopharmacol; 2016 Jan; 30():74-84. PubMed ID: 26655877 [TBL] [Abstract][Full Text] [Related]
3. The Role of Tissue-Resident Macrophages in the Development and Treatment of Inflammatory Bowel Disease. Ma S; Zhang J; Liu H; Li S; Wang Q Front Cell Dev Biol; 2022; 10():896591. PubMed ID: 35721513 [TBL] [Abstract][Full Text] [Related]
4. The Probiotic Mixture VSL#3 Alters the Morphology and Secretion Profile of Both Polarized and Unpolarized Human Macrophages in a Polarization-Dependent Manner. Isidro RA; Bonilla FJ; Pagan H; Cruz ML; Lopez P; Godoy L; Hernandez S; Loucil-Alicea RY; Rivera-Amill V; Yamamura Y; Isidro AA; Appleyard CB J Clin Cell Immunol; 2014 Jun; 5(3):1000227. PubMed ID: 25177525 [TBL] [Abstract][Full Text] [Related]
5. Monocyte and M1 Macrophage-induced Barrier Defect Contributes to Chronic Intestinal Inflammation in IBD. Lissner D; Schumann M; Batra A; Kredel LI; Kühl AA; Erben U; May C; Schulzke JD; Siegmund B Inflamm Bowel Dis; 2015 Jun; 21(6):1297-305. PubMed ID: 25901973 [TBL] [Abstract][Full Text] [Related]
7. Xu YW; Xing RX; Zhang WH; Li L; Wu Y; Hu J; Wang C; Luo QL; Shen JL; Chen X World J Gastroenterol; 2019 Dec; 25(45):6634-6652. PubMed ID: 31832003 [TBL] [Abstract][Full Text] [Related]
8. Macrophage-derived exosomes promote intestinal mucosal barrier dysfunction in inflammatory bowel disease by regulating TMIGD1 via mircroRNA-223. Chang X; Song YH; Xia T; He ZX; Zhao SB; Wang ZJ; Gu L; Li ZS; Xu C; Wang SL; Bai Y Int Immunopharmacol; 2023 Aug; 121():110447. PubMed ID: 37301121 [TBL] [Abstract][Full Text] [Related]
9. Current Status of M1 and M2 Macrophages Pathway as Drug Targets for Inflammatory Bowel Disease. Seyedizade SS; Afshari K; Bayat S; Rahmani F; Momtaz S; Rezaei N; Abdolghaffari AH Arch Immunol Ther Exp (Warsz); 2020 Apr; 68(2):10. PubMed ID: 32239308 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of FABP5 attenuates inflammatory bowel disease by modulating macrophage alternative activation. Xu J; Zheng B; Xie C; Zhao Y; Wu H; Wang Y; Guan X; Lei X; Liu D; Lou X; Chen X; Huang Y Biochem Pharmacol; 2024 Jan; 219():115974. PubMed ID: 38081366 [TBL] [Abstract][Full Text] [Related]
11. The Anti-Inflammatory Effects of Adipose Tissue Mesenchymal Stem Cell Exosomes in a Mouse Model of Inflammatory Bowel Disease. Lee JH; Lötvall J; Cho BS Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069197 [TBL] [Abstract][Full Text] [Related]
12. Macrophage polarization in inflammatory bowel disease. Zhang K; Guo J; Yan W; Xu L Cell Commun Signal; 2023 Dec; 21(1):367. PubMed ID: 38129886 [TBL] [Abstract][Full Text] [Related]
13. Plant-Derived Exosomes as a Drug-Delivery Approach for the Treatment of Inflammatory Bowel Disease and Colitis-Associated Cancer. Cai Y; Zhang L; Zhang Y; Lu R Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456656 [TBL] [Abstract][Full Text] [Related]
14. Exosomes Derived From M2b Macrophages Attenuate DSS-Induced Colitis. Yang R; Liao Y; Wang L; He P; Hu Y; Yuan D; Wu Z; Sun X Front Immunol; 2019; 10():2346. PubMed ID: 31749791 [TBL] [Abstract][Full Text] [Related]
15. YAP Aggravates Inflammatory Bowel Disease by Regulating M1/M2 Macrophage Polarization and Gut Microbial Homeostasis. Zhou X; Li W; Wang S; Zhang P; Wang Q; Xiao J; Zhang C; Zheng X; Xu X; Xue S; Hui L; Ji H; Wei B; Wang H Cell Rep; 2019 Apr; 27(4):1176-1189.e5. PubMed ID: 31018132 [TBL] [Abstract][Full Text] [Related]
16. Th1 promotes M1 polarization of intestinal macrophages to regulate colitis-related mucosal barrier damage. Ruan S; Xu L; Sheng Y; Wang J; Zhou X; Zhang C; Guo L; Li W; Han C Aging (Albany NY); 2023 Apr; 15(14):6721-6735. PubMed ID: 37494667 [TBL] [Abstract][Full Text] [Related]
17. Turmeric-derived nanovesicles as novel nanobiologics for targeted therapy of ulcerative colitis. Gao C; Zhou Y; Chen Z; Li H; Xiao Y; Hao W; Zhu Y; Vong CT; Farag MA; Wang Y; Wang S Theranostics; 2022; 12(12):5596-5614. PubMed ID: 35910802 [No Abstract] [Full Text] [Related]
18. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium. Pedersen G Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335 [TBL] [Abstract][Full Text] [Related]
19. Two-Sample Mendelian Randomization Analysis Investigates Causal Associations Between Gut Microbial Genera and Inflammatory Bowel Disease, and Specificity Causal Associations in Ulcerative Colitis or Crohn's Disease. Liu B; Ye D; Yang H; Song J; Sun X; Mao Y; He Z Front Immunol; 2022; 13():921546. PubMed ID: 35860271 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-9a-5p-NOX4 inhibits intestinal inflammatory injury by regulating the M1 polarization of intestinal macrophages. Li W; Sheng Y; Wang J; Wu S; Han C J Biochem Mol Toxicol; 2023 Feb; 37(2):e23245. PubMed ID: 36281492 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]